Join
Live feed
·
NEWSReleasevia Quantisnow
Sunshine Biopharma Inc. logo

Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology

ByQuantisnow·Wall Street's wire, on your screen.
SBFM· Sunshine Biopharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SBFM (Sunshine Biopharma Inc.) and more on Quantisnow.